MIKE SNOWDEN

Dr Mike Snowden is a Senior Vice President at AstraZeneca, leading the Discovery Sciences department within R&D Biopharmaceuticals. Mike joined AstraZeneca 9 years ago after more than 25 years in preclinical science. Graduating as a biochemist, with a PhD and postDoc in molecular biology, Mike started his Pharmaceutical career in anti-infectives, moving to Cardiovascular, Respiratory and then Neuroscience drug discovery where he was the principle enzymologist and kineticist in a number of novel drug discovery targets. After a 2-year appointment as Head of Business Development and Outsourcing for the pre-clinical organization at GSK, Mike joined AZ as Head of Head of Discovery Sciences. Discovery Sciences is a preclinical department, focused on providing core scientific capabilities across all therapy areas in AZ. Mike has very wide research interests including structural and biophysical technology platforms for discovery and he is currently focusing on advances in gene editing technologies for pre-clinical and clinical use.